Chief physician of medical oncology, national second-level professor, master tutor

Fetal hepatocyte suspension infusion in the treatment of 17 cases of decompensated cirrhosis

2024年09月18日

Qi YanchaoCheng XinchaoMai LingWang YanfangWang YanBuxiaLi HuaibinShangjiaGao PingZhang Yanrui

1. Henan Cancer Institute 2. Henan Cancer Institute 3. Henan Cancer Institute 4. Henan Cancer Institute 5. Henan Cancer Institute 6. Henan Cancer Institute 7. Henan Provincial People's Hospital 8. Henan Provincial People's Hospital 9. Xinjiang Shihezi City People's Hospital 10. Henan Provincial People's Hospital Zhengzhou 45000311. Zhengzhou 45000312. Zhengzhou 45000313. Zhengzhou 45000314. Zhengzhou 45000315. Zhengzhou 45000316. Zhengzhou 45000317. Zhengzhou 45000318. Zhengzhou 450003

Abstract: Seventeen patients with liver cirrhosis were treated with fetal hepatocyte suspension as adjuvant therapy in addition to regular therapy. One month later, abdominal distension, anorexia, ascites, splenomegaly, coagulation dysfunction and serum protein were significantly improved compared with the control group. The authors believe that fetal hepatocyte suspension infusion has a good effect on liver cirrhosis without side effects.

  • Album: Medical and Health Technology
  • Special Topics: Diseases of the Digestive System

Fetal Hepatocyte Suspension Infusion for 17 Cases of Decompensated Cirrhosis_Qi Yanchao. pdf

Related Content


undefined

undefined